glp-1 medications list Receptor Agonists Decoding GLP-1 Weight Loss Medications

Activating MC1R, MC3R, and MC4R with high potency and producing the full spectrum of biological outputs associated with melanocortin receptor activation across peripheral and central target tissues simultaneously

First published in Cell (2017), this peptide has been studied in the context of senolytics, cellular senescence, and longevity research

20 (S)-ginsenoside rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin

GLP-1 treatment protects against EndMT through inhibiting the activation of poly (ADP-ribose) polymerase 1 (PARP-1) which can elicit Smad3 and transforming growth factor (TGF)-1 responses